Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Be Well: Building Strength, Cardio and Mindfulness at 'The Class'
The NASA Artemis 3 mission in 2025 plans to investigate whether microorganisms may have survived in the moon's permanently shadowed craters .
According to NASA, a "potentially dangerous" asteroid about the size of a bridge narrowly passed Earth on Monday.
A New Hampshire mountain known for its extreme weather conditions has recorded its snowiest June in 91 years of recordkeeping.
Be Well: Improve Your Flexibility With These Chair Exercises
Walmart is expanding its HIV treatments, planning to add over 80 specialty facilities across nearly a dozen states by the end of the year.
A Food and Drug Administration advisory panel met to discuss regulatory approval for the Alzheimer's drug, Leqembi.
Air quality on the East Coast has improved to at least a moderate level and will continue getting better by the weekend.
A new study from Columbia University has found that taurina, a type of amino acid known mostly as an ingredient in energy drinks, extended the life of worms, mice and monkeys.
Artechouse, a digital art studio in New York City, has a new exhibition that lets visitors experience never-before-seen images that the James Webb space telescope captured. Cheddar News takes a peek inside the newest immersive experience.
Load More